THOMAS KOSH: Open Payments
NPI 1881061208 · ROWLETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,033 in 86 payments from 29 companies in 2025. Trend: 2023 $2,387 · 2024 $4,109 · 2025 $3,033
Food & beverage: $1,763Long term medical supply or device loan: $1,000Education: $270
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $1,029 |
| Daiichi Sankyo Inc. | 7 | $375 |
| Janssen Biotech, Inc. | 5 | $182 |
| E.R. Squibb & Sons, L.L.C. | 10 | $170 |
| Tempus AI, Inc | 6 | $142 |
| PFIZER INC. | 4 | $100 |
| ABBVIE INC. | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $83 |
| Karyopharm Therapeutics Inc. | 3 | $81 |
| Geron Corporation | 3 | $75 |
Products named: KISQALI, ENHERTU, XT CDX, ERLEADA, OPDIVO, XPOVIO, RYTELO, Nubeqa.
Industry payments across TX — which companies pay providers there.
